Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...

The phase 3 POETYK PsA-1 trial evaluated the drug in patients who were not previously treated with a biologic ...

In its latest update of AXS-05, Axsome reported that the 295-patient phase 3 ACCORD-2 trial met its primary endpoint, with ...

Events 4 Healthcare specialise in delivering bespoke events for the Healthcare and Pharmaceutical industry. We conceive and deliver Joint Working projects and produce medical education programmes, ...

Durbin is one of the world’s leading specialist medical suppliers. Established nearly 50 years ago in 1963, we source and distribute pharmaceuticals, medical equipment and consumable supplies to ...